Evaluation of PDE4 inhibition for COPD

References

• AlpSSkryganMSchmidtWE2006Sildenafil improves hemodynamic parameters in COPD-an investigation of six patientsPulm Pharmacol Ther193869016291503
   PubMed Web of Science ®Google Scholar
• Altana2005aALTANA has withdrawn the EU marketing authorisation application for Daxas. [online]Accessed 16 June 2006 URL: http://www.altana.com/files/pressemeldungen/altana_pm_2005-11-15_b2771aa087.pdf
   Google Scholar
• Altana2005bTop line results of first one-year COPD study with Daxas [online]Accessed 16 June 2006 URL:http://www.altana.com/files/pressemeldungen/altana_pm_2005-07-01_d26089802f.pdf
   Google Scholar
• BaillieGMacKenzieSJHouslayMD2001Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK)Mol Pharmacol6011001111641439
   PubMed Web of Science ®Google Scholar
• BarberaJARogerNRocaJ1996Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary diseaseLancet347436408618485
   PubMed Web of Science ®Google Scholar
• BarberaJAPeinadoVISantosS2003Pulmonary hypertension in chronic obstructive pulmonary diseaseEur Respir J2189290512765440
   PubMed Web of Science ®Google Scholar
• BarnesPJ2003Theophylline: new perspectives for an old drugAm J Respir Crit Care Med1678131812623857
   PubMed Web of Science ®Google Scholar
• BrownDMDonaldsonKBormPJ2004Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particlesAm J Physiology Lung Cell Mol Physiol286L34453
   PubMed Web of Science ®Google Scholar
• BundschuhDSEltzeMBarsigJ2001In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitorJ Pharmacol Exp Ther2972809011259555
   PubMed Web of Science ®Google Scholar
• CardGLEnglandBPSuzukiY2004Structural basis for the activity of drugs that inhibit phosphodiesterasesStructure1222334715576036
   PubMed Web of Science ®Google Scholar
• ContiMRichterWMehatsC2003Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signalingJ Biol Chem2785493612493749
   PubMed Web of Science ®Google Scholar
• de WittBJMarroneJRKadowitzPJ2000Comparison of responses to siguazodan, rolipram, and zaprinast in the feline pulmonary vascular bedEur J Pharmacol406233811020486
   PubMed Web of Science ®Google Scholar
• DoiMNakanoKHiramotoT2003Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemiaRespir Med979152012924518
   PubMed Web of Science ®Google Scholar
• FilosaJAPutnamRW2003Multiple targets of chemosensitive signaling in locus coeruleus neurons: role of K+ and Ca2+ channelsAm J Physiol Cell Physiol284C1455512388081
   PubMed Web of Science ®Google Scholar
• GambleEGrootendorstDCBrightlingCE2003Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1689768212816740
   PubMed Web of Science ®Google Scholar
• GiembyczMA2001Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary diseaseExpert Opin Investig Drugs10136179
   PubMed Web of Science ®Google Scholar
• GiembyczMA20024D or not 4D - the emetogenic basis of PDE4 inhibitors uncovered?Trends Pharmacol Sci2354812457768
   PubMedGoogle Scholar
• GiembyczMA2005Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary diseaseProc Am Thorac Soc232633 discussion 340–116267357
   PubMedGoogle Scholar
• GOLD2005Executive summary: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [online]Accessed 16 June 2006 URL: http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=996
   Google Scholar
• HolbrookMGozzardNJamesT1996Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitorBr J Pharmacol11811922008818343
   PubMed Web of Science ®Google Scholar
• HouslayMDAdamsDR2003PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalizationBiochem J37011812444918
   PubMed Web of Science ®Google Scholar
• HuaiQWangHSunY2003Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivityStructure118657312842049
   PubMed Web of Science ®Google Scholar
• HuaiQLiuYFrancisSH2004Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivityJ Biol Chem2791309510114668322
   PubMed Web of Science ®Google Scholar
• HuangZDucharmeYMacdonaldD2001The next generation of PDE4 inhibitorsCurr Opin Chem Biol5432811470607
   PubMed Web of Science ®Google Scholar
• KumarRKHerbertCThomasPS2003Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthmaJ Pharmacol Exp Ther3073495512954795
   PubMed Web of Science ®Google Scholar
• LagenteVMartin-ChoulyCBoichotE2005Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseasesMem Inst Oswaldo Cruz100Suppl 1131615962112
   PubMed Web of Science ®Google Scholar
• LamontagneSMeadowsELukP2001Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkeyBrain Res920849611716814
   PubMed Web of Science ®Google Scholar
• LeadDiscovery2006Phosphodiesterase 4 (PDE4) & phosphodiesterase 5 (PDE5) inhibitors [online]Accessed 16 June 2006 URL: http://www.leaddiscovery.co.uk/reports/Phosphodiesterase-library.html
   Google Scholar
• LeeMEMarkowitzJLeeJO2002Crystal structure of phosphodi-esterase 4D and inhibitor complex(1)FEBS Lett53053812387865
   PubMed Web of Science ®Google Scholar
• LipworthBJ2005Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary diseaseLancet36594541677515639300
   PubMed Web of Science ®Google Scholar
• LiuHPalmerDJimmoSL2000Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cellsJ Biol Chem275266152410851231
   PubMed Web of Science ®Google Scholar
• MehatsCJinSLWahlstromJ2003PDE4D plays a critical role in the control of airway smooth muscle contractionFASEB J1718314114519662
   PubMed Web of Science ®Google Scholar
• National Institutes of Health2006Sildenafil for Chronic Obstructive Pulmonary Disease [online]Accessed 16 June 2006 URL: http://www.clinicaltrials.gov/ct/gui/show/NCT104637
   Google Scholar
• NestlerEJAlrejaMAghajanianGK1999Molecular control of locus coeruleus neurotransmissionBiol Psychiatry461131910560020
   PubMed Web of Science ®Google Scholar
• OdingoJO2005Inhibitors of PDE4: a review of recent patent literatureExpert Opinion on Therapeutic Patents1577387
   Web of Science ®Google Scholar
• PackerMCarverJRRodehefferRJ1991Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research GroupN Engl J Med3251468751944425
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCalverleyPM2001Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med16312567611316667
   PubMedGoogle Scholar
• Pharmiweb2005Daxas deal leaves Altana short of breath [online]Accessed 16 June 2006 URL: http://www.pharmiweb.com/features/feature.asp?ROW_ID=624
   Google Scholar
• Plexxikon, Inc2005PDE4 inhibitor factor sheet [online]Accessed 16 June 2006 URL: http://www.plexxikon.com/plx-pde4.pdf
   Google Scholar
• ProfitaMChiapparaGMirabellaF2003Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPDThorax58573912832668
   PubMed Web of Science ®Google Scholar
• RabeKFBatemanEDO’DonnellD2005Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialLancet36694855637116099292
   PubMed Web of Science ®Google Scholar
• RobichaudAStamatiouPBJinSL2002Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesisJ Clin Invest11010455212370283
   PubMed Web of Science ®Google Scholar
• SajkovDWangTFrithPA1997A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPDChest1111622309187185
   PubMed Web of Science ®Google Scholar
• SchmidtDTWatsonNDentG2000The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airwaysBr J Pharmacol13116071811139438
   PubMed Web of Science ®Google Scholar
• SchermulyRTRoehlAWeissmannN2000Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeJ Pharmacol Exp Ther2925122010640287
   PubMed Web of Science ®Google Scholar
• SoderlingSHBeavoJA2000Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functionsCurr Opin Cell Biol12174910712916
   PubMed Web of Science ®Google Scholar
• SotoFJHananiaNA2005Selective phosphodiesterase-4 inhibitors in chronic obstructive lung diseaseCurr Opin Pulm Med111293415699784
   PubMed Web of Science ®Google Scholar
• SpinaD2003Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung diseaseDrugs6325759414636078
   PubMed Web of Science ®Google Scholar
• SpinaD2004The potential of PDE4 inhibitors in respiratory diseaseCurr Drug Targets Inflamm Allergy3231615379590
   PubMedGoogle Scholar
• SzaboCHaskoGNemethZH1997Calcium entry blockers increase interleukin-10 production in endotoxemiaShock730479110418
   PubMed Web of Science ®Google Scholar
• TakedaNMoritaMHoriiA2001Neural mechanisms of motion sicknessJ Med Invest48445911286016
   PubMedGoogle Scholar
• TenorHHatzelmannAChurchMK1996Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjectsBr J Pharmacol1181727358842438
   PubMed Web of Science ®Google Scholar
• TokuyamaSHoIK1996Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent ratsBrain Res72221268813371
   PubMed Web of Science ®Google Scholar
• WallaceDAJohnstonLAHustonE2005Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase geneMol Pharmacol6719203415738310
   PubMed Web of Science ®Google Scholar
• WangDWangT2005Novel approaches to using PDE4 inhibitors for antihypertensive therapyCurr Opin Investig Drugs62838
   Google Scholar
• WilliamsJTNorthRAShefnerSA1984Membrane properties of rat locus coeruleus neuronesNeuroscience13137566493483
   PubMed Web of Science ®Google Scholar
• WorleyJF3rdKotlikoffMI1990Dihydropyridine-sensitive single calcium channels in airway smooth muscle cellsAm J Physiol259L468801701979
   PubMed Web of Science ®Google Scholar
• WollinLBundschuhDSWohlsenA2005Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitorsPulm Pharmacol Ther1027 Epub ahead of print
   Web of Science ®Google Scholar